Evidence map›Paper›PMID 35924413›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019.

Adham Mohamed, Shelby M Shemanski, Mohamed O Saad, Jeannette Ploetz, Michelle M Haines, Andrew B Schlachter, Majdi S Hamarshi

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Adham Mohamed24091Saint Luke's Hospital of Kansas City, Kansas City, MO, USA.ORCID https://orcid.org/0000-0003-3137-7049
Shelby M Shemanski24091Saint Luke's Hospital of Kansas City, Kansas City, MO, USA.ORCID https://orcid.org/0000-0001-9919-1844
Mohamed O SaadAl-Wakra Hospital, 36977Hamad Medical Corporation, Doha, Qatar.
Jeannette Ploetz24091Saint Luke's Hospital of Kansas City, Kansas City, MO, USA.
Michelle M Haines24091Saint Luke's Hospital of Kansas City, Kansas City, MO, USA.
Andrew B Schlachter24091Saint Luke's Hospital of Kansas City, Kansas City, MO, USA.
Majdi S Hamarshi24091Saint Luke's Hospital of Kansas City, Kansas City, MO, USA.
Saint Luke's Hospital · USHamad Medical Corporation · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Venous ThromboembolismAnticoagulantsCritical IllnessHemorrhageHeparin, Low-Molecular-WeightHumansRetrospective StudiesAnticoagulantsHeparin, Low-Molecular-WeightanticoagulationbleedingCOVID-19thromboprophylaxisvenous thromboembolism

Identifiers

PMID35924413
PMCPMC9358597
OpenAlexW4289827071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.